Showing results (261-270 of 324) with videos related to

Sort By:
Pageof 33
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 15, 2006
[Long-term outcomes of 392 non-Hodgkin's lymphoma patients treated with pirarubicin based regimens]Hui-Qiang Huang, Yu-Long Peng, Qing-Qing Cai, et al.
Therapeutic Advances in Medical Oncology|January 11, 2024
Clinical and molecular characteristics of <i>RNF43</i> mutations as promising prognostic biomarkers in colorectal cancerZi-Yao Huang, Lei Wen, Liu-Fang Ye, et al.
Zhonghua Nei Ke Za Zhi|May 16, 2008
[A survival of 103 cases of T-cell non-Hodgkin lymphoma]Yan-Xia Shi, Rou-Jun Peng, Su-Xia Lin, et al.
Cancer Science|October 4, 2018
Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancerMing-Ming He, Feng Wang, Ying Jin, et al.
JAMA Network Open|April 9, 2021
Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical TrialDe-Shen Wang, Ming-Tao Hu, Zhi-Qiang Wang, et al.
Cancer Management and Research|May 24, 2019
Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patientsRui Gong, Yuan He, Xiao-Yun Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 12, 2014
Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observationMiao-zhen Qiu, Xiao-li Wei, Dong-sheng Zhang, et al.
NPJ Precision Oncology|May 13, 2024
Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysisZi-Jing Li, William Pat Fong, Dong-Sheng Zhang, et al.
Cell Reports. Medicine|February 19, 2025
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumorsXiao-Li Wei, Hao-Xiang Wu, Dan-Yun Ruan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 22, 2003
[Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen]Hui-Qiang Huang, Wen-Qi Jiang, Wei Wang, et al.
Pageof 33